Please join us at the 27th National Institute of Health (NIH) Tissue Chip Consortium Joint Meeting with C-Path’s predictive safety testing team. The Complex In Vitro Model Workshop will be held on March 5-6, 2026 at the National Cancer Institute in Rockville, Md. Over the past 13 years, the NIH has brought together members of the NIH Tissue Chip Consortium, including funded academic investigators, members of the pharmaceutical industry, and government agencies to accelerate the use, adoption, and ultimately dissemination of tissue chip technology across the United States.
This year, NIH has partnered with C-Path’s Predictive Safety Testing Consortium, a recognized global leader in drug development, to put together a joint meeting at no registration cost focused on accelerating the employment of tissue chips within the drug development pipeline. Day 1 (March 5) will focus on Contexts of Use for Today and Tomorrow and Evidentiary Considerations for MPS, while Day 2 (March 6) will focus on Integration of In-Silico NAMs, including tissue chips.
